Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03514771Completed
Randomised, single-blind trial. Primary endpoint: Adverse events associated with early non-ablative fractional laser resurfacing at 4 months. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03514771.